INDOLEAMINE 2,3-DIOXYGENASE IN OPPORTUNISTIC INFECTIONS

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 18977
Amount: $50,000.00
Phase: Phase I
Program: SBIR
Awards Year: 1992
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
Hipple Cancer Research Center
4100 South Kettering Blvd, Dayton, OH, 45439
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Wei Dai
 (513) 293-8508
Business Contact
Phone: () -
Research Institution
N/A
Abstract
CENTRAL NERVOUS SYSTEM TOXOPLASMOSIS HAS CAUSED DISABILITY AND DEATH IN UP TO 30% OF PATIENTS WITH AIDS. CURRENT CLINICAL TREATMENT FOR TOXOPLASMA INFECTION IS MAINLY CHEMOTHERAPEUTICAL, WHICH IS OFTEN ASSOCIATED WITH DOSE-RELATED BONE MARROW SUPPRESSION. COMPLETE REMISSION OF THE INFECTION DEPENDS LARGELY ON THE ADEQUATE RESTORATION OF THE CELL-MEDIATED IMMUNE SYSTEM OF THE PATIENTS AND THUS, IT POSES A CONTINUOUS THREAT TO AIDS PATIENTS. AN ALTERNATIVE TREATMENT USING RECOMBINANT INTERFERON-GAMMA (IFN-GAMMA) HAS BEEN PROPOSED SINCE IFN-GAMMA, A CD4+T CELL PRODUCT, BLOCKS THE GROWTH OF T GONDII IN A VARIETY OF TISSUES AND CELLS. THIS IFN-GAMMA-MEDIATE ANTI-TOXOPLASMIC ACTIVITY IS STRONGLY CORRELATED WITH THE DEGRADATION OF THE ESSENTIAL AMINO ACID L-TRYPTOPHAN IN VITRO. DESTRUCTION L-TRYPTOPHAN IS DUE TO THE INCREASED ACTIVITY OF INDOLEAMINE 2,3 DIOXYGENASE (ISO) WHICH IS IN TURN TRANSCRIPTIONALLY ACTIVATED BY IFN-GAMMA. IT HAS BEEN SUGGESTED THAT T GONDII INFECTION IS PRIMARILY CONTROLLED BY IDO ACTIVITY INDUCED BY IFN-GAMMA DERIVED FROM CD4+ T LYMPHOCYTES. THEREFORE, WE WILL INVESTIGATE THE ROLE OF IDO IN HOST DEFENSE AGAINST T GONDII INFECTION, AND SPECIFICALLY TO DETERMINE WHETHER IDO ACTIVITY ALONE, EXPRESSED VIA STABLE TRANSFECTION OF IDO CDNA CONTROLLED BY A METALLOTHIONEIN INDUCIBLE PROMOTER, BLOCKS THE GROWTH OF T GONDII IN CULTURED HUMAN FIBROBLASTS AND MACROPHAGE CELL LINE. ELUCIDATION OF THE ROLE OF IDO IN BLOCKING T GONDII REPLICATION WILL PROVIDE NOT ONLY HOST DEFENSE MECHANISM BUT ALO NEW CONCEPT FOR DEVELOPING EFFECTIVE DRUGS FOR PREVENTION AND TREATMENT OF TOXOPLASMOSIS IN AIDS PATIENTS.

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government